Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure

Neurobiology of Aging

Volumn 35, Issue 11, 2014, Pages 2504-2513

  Warstadt, Nicholus M ^a   Dennis, Emily L ^a   Jahanshad, Neda ^a   Kohannim, Omid ^b   Nir, Talia M ^a   McMahon, Katie L ^c   de Zubicaray, Greig I ^c   Montgomery, Grant W ^d   Henders, Anjali K ^d   Martin, Nicholas G ^d   Whitfield, John B ^d   Jack, Clifford R ^e   Bernstein, Matt A ^e   Weiner, Michael W ^f,g   Toga, Arthur W ^a   Wright, Margaret J ^c,d   Thompson, Paul M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Brain structure; Cholesterol; Development; DTI; Imaging genetics

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; CETP PROTEIN, HUMAN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CETP GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE NUCLEOTIDE POLYMORPHISM; WHITE MATTER; YOUNG ADULT; ALLELE; ANISOTROPY; BLOOD; FOLLOW UP; FORECASTING; GENETICS; METABOLISM; MYELIN SHEATH; PATHOLOGY; RISK;

ADULT; AGING; ALLELES; ALZHEIMER DISEASE; ANISOTROPY; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MYELIN SHEATH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; WHITE MATTER; YOUNG ADULT;

EID: 84922848845     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.05.024     Document Type: Article

References (90)

1. Annett M. Aclassification of hand preference by association analysis. Br. J. Psychol. 1970, 61:303-321.
2. Arias-Vasquez A., Isaacs A., Aulchenko Y.S., Hofman A., Oostra B.A., Breteler M., van Duijn C.M. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Neurogenetics 2007, 8:189-193.
3. Assaf Y., Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J.Mol. Neurosci. 2008, 34:51-61.
4. Asselbergs F.W., Guo Y., van Iperen E.P., Sivapalaratnam S., Tragante V., Lanktree M.B., Lange L.A., Almoguera B., Appelman Y.E., Barnard J., Baumert J., Beitelshees A.L., Bhangale T.R., Chen Y.I., Gaunt T.R., Gong Y., Hopewell J.C., Johnson T., Kleber M.E., Langaee T.Y., Li M., Li Y.R., Liu K., McDonough C.W., Meijs M.F.L., Middelberg R.P.S., Musunuru K., Nelson C.P., O'Connell J.R., Padmanabhan S., Pankow J.S., Pankratz N., Rafelt S., Rajagopalan R., Romaine S.P.R., Schork N.J., Shaffer J., Shen H., Smith E.N., Tischfield S.E., van Vliet-Ostaptchouk J.V., Verweij N., Volcik K.A., Zhang L., Bailey K.R., Bailey K.M., Bauer F., Boer J.M.A., Braund P.S., Burt A., Burton P.R., Buxbaum S.G., Chen W., Cooper-Dehoff R.M., Cupples L.A., DeJong J.S., Delles C., Duggan D., Fornage M., Furlong C.E., Glazer N., Gums J.G., Hastie C., Holmes M.V., Illig T., Kirkland S.A., Kivimaki M., Klein R., Klein B.E., Kooperberg C., Kottke-Marchant K., Kumari M., LaCroix A.Z., Mallela L., Murugesan G., Ordovas J., Ouwehand W.H., Post W.S., Saxena R., Scharnagl H., Schreiner P.J., Shah T., Shields D.C., Shimbo D., Srinivasan S.R., Stolk R.P., Swerdlow D.I., Taylor H.A., Topol E.J., Toskala E., van Pelt J.L., van Setten J., Yusuf S., Whittaker J.C., Zwinderman A.H., Anand S.S., Balmforth A.J., Berenson G.S., Bezzina C.R., Boehm B.O., Boerwinkle E., Casas J.P., Caulfield M.J., Clarke R., Connell J.M., Cruickshanks K.J., Davidson K.W., Day I.N.M., de Bakker P.I.W., Doevendans P.A., Dominiczak A.F., Hall A.S., Hartman C.A., Hengstenberg C., Hillege H.L., Hofker M.H., Humphries S.E., Jarvik G.P., Johnson J.A., Kaess B.M., Kathiresan S., Koenig W., Lawlor D.A., März W., Melander O., Mitchell B.D., Montgomery G.W., Munroe P.B., Murray S.S., Newhouse S.J., Onland-Moret N.C., Poulter N., Psaty B., Redline S., Rich S.S., Rotter J.I., Schunkert H., Sever P., Shuldiner A.R., Silverstein R.L., Stanton A., Thorand B., Trip M.D., Tsai M.Y., van der Harst P., van der Schoot E., van der Schouw Y.T., Verschuren W.M.M., Watkins H., Wilde A.A.M., Wolffenbuttel B.H.R., Whitfield J.B., Hovingh G.K., Ballantyne C.M., Wijmenga C., Reilly M.P., Martin N.G., Wilson J.G., Rader D.J., Samani N.J., Reiner A.P., Hegele R.A., Kastelein J.J.P., Hingorani A.D., Talmud P.J., Hakonarson H., Elbers C.C., Keating B.J., Drenos F. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 2012, 91:823-838.
5. Asselbergs F.W., Lovering R.C., Drenos F. Progress in genetic association studies of plasma lipids. Curr. Opin. Lipidol. 2013, 24:123-128.
6. Astarita G., Jung K.M., Berchtold N.C., Nguyen V.Q., Gillen D.L., Head E., Cotman C.W., Piomelli D. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 5, e12538. PLoS One 2010, 5:e12538.
7. Aukema E.J., Caan M.W., Oudhuis N., Majoie C.B., Vos F.M., Reneman L., Last B.F., Grootenhuis M.A., Schouten-van Meeteren A.Y.N. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:837-843.
8. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2011, 32:1341-1371.
9. Bartzokis G., Cummings J.L., Sultzer D., Henderson V.W., Nuechterlein K.H., Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch. Neurol. 2003, 60:393-398.
10. Bartzokis G., Sultzer D., Lu P.H., Nuechterlein K.H., Mintz J., Cummings J.L. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 2004, 25:843-851.
11. Barysheva M., Jahanshad N., Foland-Ross L., Altshuler L.L., Thompson P.M. White matter microstructural abnormalities in bipolar disorder: a whole brain diffusion tensor imaging study. Neuroimage Clin. 2013, 2:558-568.
12. Baum L., Chen L., Masliah E., Chan Y.S., Ng H.K., Pang C.P. Lipoprotein lipase mutations and Alzheimer's disease. Am. J. Med. Genet. 1999, 88:136-139.
13. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002, 15:435-455.
14. Beaulieu C., Allen P.S. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn. Reson. Med. 1994, 32:579-583.
15. Benton D. Do low cholesterol levels slow mental processing?. Psychosom. Med. 1995, 57:50-53.
16. Bosch B., Arenaza-Urquijo E.M., Rami L., Sala-Llonch R., Junqué C., Solé-Padullés C., Bartrés-Faz D. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol. Aging 2012, 33:61-74.
17. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed in vivo ing diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 2002, 72:742-746.
18. Brun A., Englund E. Awhite matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 1986, 19:253-262.
19. Chiang M.C., Barysheva M., Shattuck D.W., Lee A.D., Madsen S.K., Avedissian C., Klunder A.D., Toga A.W., McMahon K.L., de Zubicaray G.I., Wright M.J., Srivastava A., Balov N., Thompson P.M. Genetics of brain fiber architecture and intellectual performance. J. Neurosci 2009, 29:2212-2224.
20. Chua T.C., Wen W., Slavin M.J., Sachdev P.S. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr. Opin Neurol 2008, 21:83-92.
21. Cohen J.I., Cazettes F., Convit A. Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults, a diffusion tensor imaging study. Neuroradiol J 2011, 1(21):989.
22. Derouesne C., Thibault S., Lagha-Pierucci S., Baudouin-Madec V., Ancri D., Lacomblez L. Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int. J. Geriatr. Psychiatry 1999, 14:1019-1030.
23. Dietschy J.M., Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J.Lipid Res. 2004, 45:1375-1397.
24. Dzamko N., Alessi D.R., Birk O.S. Enzyme may be responsible for regulating deleterious effects of Alzheimer's disease in the brain. Future Neurol. 2011, 6:9-11.
25. Elias P.K., Elias M.F., D'Agostino R.B., Sullivan L.M., Wolf P.A. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom.Med 2005, 67:24-30.
26. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15(4):870-878.
27. Grieve S.M., Williams L.M., Paul R.H., Clark C.R., Gordon E. Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study. AJNR Am. J. Neuroradiol. 2007, 28:226-235.
28. Gustafsen C., Glerup S., Pallesen L.T., Olsen D., Andersen O.M., Nykjaer A., Madsen P., Petersen C.M. Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein. J. Neurosci 2013, 33:64-71.
29. Hüppi P.S., Dubois J. Diffusion tensor imaging of brain development. Semin Fetal Neonatal Med 2006, 11(6):489-497.
30. Ikeda T., Yamada M. [Risk factors for Alzheimer's disease]. Brain Nerve 2010, 62:679-690.
31. Inazu A., Brown M.L., Hesler C.B., Agellon L.B., Koizumi J., Takata K., Maruhama Y., Mabuchi H., Tall A.R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med 1990, 323:1234-1238.
32. Jahanshad N., Kochunov P.V., Sprooten E., Mandl R.C., Nichols T.E., Almasy L., Blangero J., Brouwer R.M., Curran J.E., de Zubicaray G.I., Duggirala R., Fox P.T., Hong L.E., Landman B.A., Martin N.G., McMahon K.L., Medland S.E., Mitchell B.D., Olvera R.L., Peterson C.P., Starro J.M., Sussmann J.E., Toga A.W., Wardlaw J.M., Wright M.J., Hulshoff Pol H.E., Bastin M.E., McIntosh A.M., Deary I.J., Thompson P.M., Glahn D.C. Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage 2013, 81:455-469.
33. Jahanshad N., Kohannim O., Hibar D.P., Stein J.L., McMahon K.L., de Zubicaray G.I., Medland S.E., Montgomery G.W., Whitfield J.B., Martin N.G., Wright M.J., Toga A.W., Thompson P.M. Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc. Natl. Acad. Sci. 2012, 109:E851-E859.
34. Jernigan T.L., Gamst A.C., Fennema-Notestine C., Ostergaard A.L. More "mapping" in brain mapping: statistical comparison of effects. Hum. Brain Mapp. 2003, 19:90-95.
35. Jin Y., Shi Y., Joshi S.H., Jahanshad N., Zhan L., De Zubicaray G.I., Thompson P.M. Heritability of white matter fiber tract shapes: a HARDI study of 198 twins. In Multimodal Brain Image Analysis (pp. 35-43), Held in Conjunction with MICCAI 2011, Toronto, Canada 2010.
36. Kalayci R., Kaya M., Uzun H., Bilgic B., Ahishali B., Arican N., Elmas I., Küçük M. Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats. Int. J. Neurosci 2009, 119:1881-1904.
37. Kang H.M., Zaitlen N.A., Wade C.M., Kirby A., Heckerman D., Daly M.J., Eskin E. Efficient control of population structure in model organism association mapping. Genetics 2008, 178:1709-1723.
38. Kaste M., Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke 1988, 19:1097-1100.
39. Keys A., Mickelsen O., Miller E.V., Hayes E.R., Todd R.L. The concentration of cholesterol in the blood serum of normal man and its relation to age. J.Clin. Invest 1950, 29:1347.
40. Klingberg T., Hedehus M., Temple E., Salz T., Gabrieli J.D., Moseley M.E., Poldrack R.A. Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from diffusion tensor magnetic resonance imaging. Neuron 2000, 25:493-500.
41. Kochunov P., Coyle T., Lancaster J., Robin D.A., Hardies J., Kochunov V., Bartzokis G., Stanley J., Royall D., Schlosser A.E., Null M., Fox P.T. Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging. Neuroimage 2010, 49:1190-1199.
42. Kohannim O., Jahanshad N., Braskie M.N., Stein J.L., Chiang M.C., Reese A.H., Hibar D.P., Toga A.W., McMahon K.L., de Zubicaray G.I., Medland S.E., Montgomery G.W., Martin N.G., Wright M.J., Thompson P.M. Predicting white matter integrity from multiple common genetic variants. Neuropsychopharmacology 2012, 37:2012-2019.
43. Kysenius K., Muggalla P., Matlik K., Arumae U., Huttunen H.J. PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling. Cell Mol. Life Sci. 2012, 69:1903-1916.
44. Lamsa R., Helisalmi S., Herukka S.K., Tapiola T., Pirttila T., Vepsalainen S., Hiltunen M., Soininen H. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Neurobiol. Aging 2008, 29:848-855.
45. Langers D.R., Jansen J.F., Backes W.H. Enhanced signal detection in neuroimaging by means of regional control of the global false discovery rate. Neuroimage 2007, 38:43-56.
46. Langsted A., Freiberg J.J., Nordestgaard B.G. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008, 118:2047-2056.
47. Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion tensor imaging: concepts and applications. J.Magn. Reson. Imaging 2001, 13:534-546.
48. Lebel C., Walker L., Leemans A., Phillips L., Beaulieu C. Microstructural maturation of the human brain from childhood to adulthood. Neuroimage 2008, 40:1044-1055.
49. Lee J.E., Chung M.K., Lazar M., DuBray M.B., Kim J., Bigler E.D., Alexander A.L. Astudy of diffusion tensor imaging by tissue-specific, smoothing-compensated voxel-based analysis. Neuroimage 2009, 44:870-883.
50. Manolio T.A., Ettinger W.H., Tracy R.P., Kuller L.H., Borhani N.O., Lynch J.C., Fried L.P. Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 1993, 87:728-737.
51. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.C., Otto A., Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
52. Mora S., Rifai N., Buring J.E., Ridker P.M. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008, 118:993-1001.
53. Morell P., Jurevics H. Origin of cholesterol in myelin. Neurochem. Res. 1996, 21:463-470.
54. Moseley M. Diffusion tensor imaging and aging-a review. NMR Biomed. 2002, 15:553-560.
55. Mulder S.D., Veerhuis R., Blankenstein M.A., Nielsen H.M. The effect ofamyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Exp. Neurol. 2012, 233:373-379.
56. Muldoon M.F., Ryan C.M., Matthews K.A., Manuck S.B. Serum cholesterol and intellectual performance. Psychosom Med. 1997, 59:382-387.
57. Murphy E.A., Roddey J.C., McEvoy L.K., Holland D., Hagler D.J., Dale A.M., Brewer J.B. the Alzheimer's Disease Neuroimaging Initiative. CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner. Brain Imaging Behav 2012, 6:16-26.
58. Natunen T., Helisalmi S., Vepsalainen S., Sarajarvi T., Antikainen L., Makinen P., et al. Genetic analysis of genes involved in amyloid-beta degradation and clearance in Alzheimer's disease. J.Alzheimers Dis. 2012, 28:553-559.
59. Nir T.M., Jahanshad N., Villalon-Reina J.E., Toga A.W., Jack C.R., Weiner M.W., Thompson P.M. Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. NeuroImage: Clin 2013, 3:180-195.
60. Page R.M., Munch A., Horn T., Kuhn P.H., Colombo A., Reiner O., Boutros M., Steiner H., Lichtenthaler S.F., Haass C. Loss of PAFAH1B2 reduces amyloid-beta generation by promoting the degradation of amyloid precursor protein C-terminal fragments. J. Neurosci 2012, 32:18204-18214.
61. Parente D.B., Gasparetto E.L., da Cruz L.C.H., Domingues R.C., Baptista A.C., Carvalho A.C.P., Domingues R.C. Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease. Am. J. Roentgenol. 2008, 190:1369-1374.
62. Refolo L.M., Menter B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis 2000, 7:321-331.
63. Reid P.C., Urano Y., Kodama T., Hamakubo T. Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. J.Cell Mol. Med. 2007, 11:383-392.
64. Rodriguez-Rodriguez E., Mateo I., Infante J., Llorca J., Garcia-Gorostiaga I., Vazquez-Higuera J.L., Sánchez-Juan P., Berciano J., Combarros O. Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk. Brain Res. 2009, 1280:166-171.
65. Rose S.E., Chen F., Chalk J.B., Zelaya F.O., Strugnell W.E., Benson M., Semple J., Doddrell D.M. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry 2000, 69:528-530.
66. Rose S.E., Andrew L., Chalk J.B. Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study. J.Magn. Reson. 2008, 27:20-26.
67. Roses A.D., Lutz M.W., Amrine-Madsen H., Saunders A.M., Crenshaw D.G., Sundseth S.S., Huentelman M.J., Welsh-Bohmer K.A., Reiman E.M. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010, 10:375-384.
68. Ruggeri R.B. Pharmacological inhibition for the modulation of plasma cholesterol levels and promising target for the prevention of atherosclerosis. Curr. Top. Med. Chem. 2005, 5:257-264.
69. Saher G., Brugger B., Lappe-Siefke C., Mobius W., Tozawa R., Wehr M.C., Wieland F., Ishibashi S., Klaus-Armin N. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci 2005, 8:468-475.
70. Saher G., Simons M. Cholesterol and myelin biogenesis. Subcell Biochem. 2010, 51:489-508.
71. Schaefer E.J., Audelin M.C., McNamara J.R., Shah P.K., Tayler T., Daly J.A., Augustin J.L., Seman L.J., Rubenstein J.J. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am. J. Cardiol 2001, 88:1129-1133.
72. Shobab L.A., Hsiung G.Y., Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol. 2005, 4:841-852.
73. Solfrizzi V., Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2002, 72:732-736.
74. Solomon A., Kareholt I., Ngandu T., Wolozin B., Macdonald S.W., Winblad B., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol. Aging 2009, 30:1006-1009.
75. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17:1429-1436.
76. Song S.K., Yoshino J., Le T.Q., Lin S.J., Sun S.W., Cross A.H., Armstrong R.C. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005, 26:132-140.
77. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?. Ann. N.Y Acad. Sci. 1997, 826:128-146.
78. Takahashi S., Yonezawa H., Takahashi J., Kudo M., Inoue T., Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci. Lett. 2002, 332:45-48.
79. Tall A.R. Plasma cholesteryl ester transfer protein. J.Lipid Res. 1993, 34:1255-1274.
80. Tamnes C.K., Ostby Y., Fjell A.M., Westlye L.T., Due-Tonnessen P., Walhovd K.B. Brain maturation in adolescence and young adulthood: regional age-related changes in cortical thickness and white matter volume and microstructure. Cereb. Cortex 2010, 20:534-548.
81. Tatu L., Moulin T., Bogousslavsky J., Duvernoy H. Arterial territories of human brain: brainstem and cerebellum. Neurology 1996, 47:1125-1135.
82. Thomason M.E., Thompson P.M. Diffusion imaging, white matter, and psychopathology. Annu. Rev. Clin. Psychol. 2011, 7:63-85.
83. Turley S.D., Burns D.K., Rosenfeld C.R., Dietschy J.M. Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J Lipid Res 1996, 37(9):1953-1961.
84. Ukmar M., Makuc E., Onor M.L., Garbin G., Trevisiol M., Cova M.A. Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging. Radiol. Med. 2008, 113:915-922.
85. Vuletic S., Jin L.W., Marcovina S.M., Peskind E.R., Moller T., Albers J.J. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J.Lipid Res. 2003, 44:1113-1123.
86. Waldstein S., Elias M. Neuropsychology of Cardiovascular Disease 2001, Lawrence Erlbaum Associates, Mahwah, N.J.
87. Warnick G.R., Knopp R.H., Fitzpatrick V., Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem. 1990, 36:15-19.
88. Williams V.J., Leritz E.C., Shepel J., McGlinchey R.E., Milberg W.P., Rudolph J.L., Lipsitz L.A., Salat D.H. Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum. Brain Mapp 2013, 34:1826-1841.
89. Wollmer M.A., Streffer J.R., Lutjohann D., Tsolaki M., Iakovidou V., Hegi T., Pasch T., Jung H.H., von Bergmann K., Nitsch R.M., Hock C., Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 2003, 24:421-426.
90. Xiao Z., Wang J., Chen W., Wang P., Zeng H., Chen W. Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids Health Dis. 2012, 11:163.